Toxoplasma gondii infection and chronic schizophrenia: is there any association?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Archives of Clinical Psychiatry |
Texto Completo: | https://www.revistas.usp.br/acp/article/view/144874 |
Resumo: | Background: Toxoplasma gondii (T. gondii) infection has been identified as a risk factor for schizophrenia. Objectives: Herein, we sought to evaluate the association between T. gondii infection and clinical symptoms and quality of life in patients with schizophrenia. Methods: We conducted a cross-sectional study with 48 patients with chronic schizophrenia and 40 controls. Peripheral blood was drawn, and IgM and IgG anti-T. gondii antibodies were evaluated by Enzyme-Linked Immunosorbent Assay (ELISA). Depressive, positive and negative symptoms were assessed, respectively, by the Calgary Depression Scale (CDS) and the Positive and Negative Syndrome Scale (PANSS). Cognitive performance was assessed in patients by the Brazilian version of the Schizophrenia Cognition Rating Scale (SCoRS-BR). Quality of life was assessed by the Brazilian version of the Quality of Life in Schizophrenia scale (QLS-BR). Results: The prevalence and titers of T. gondii IgM and IgG antibodies did not differ between patients and controls. The positive serology for T. gondii IgG antibodies was not associated with illness symptoms, cognitive performance, depressive symptoms or quality of life. Discussion: Our findings suggest that toxoplasmosis infection is not associated with severity of symptoms, quality of life, cognitive or depressive symptoms in schizophrenia patients. |
id |
USP-5_d6e9bcb7af2ab3ca681c6c667e1bce9a |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/144874 |
network_acronym_str |
USP-5 |
network_name_str |
Archives of Clinical Psychiatry |
repository_id_str |
|
spelling |
Toxoplasma gondii infection and chronic schizophrenia: is there any association?Toxoplasma gondiischizophreniacognitiondepressionquality of life Background: Toxoplasma gondii (T. gondii) infection has been identified as a risk factor for schizophrenia. Objectives: Herein, we sought to evaluate the association between T. gondii infection and clinical symptoms and quality of life in patients with schizophrenia. Methods: We conducted a cross-sectional study with 48 patients with chronic schizophrenia and 40 controls. Peripheral blood was drawn, and IgM and IgG anti-T. gondii antibodies were evaluated by Enzyme-Linked Immunosorbent Assay (ELISA). Depressive, positive and negative symptoms were assessed, respectively, by the Calgary Depression Scale (CDS) and the Positive and Negative Syndrome Scale (PANSS). Cognitive performance was assessed in patients by the Brazilian version of the Schizophrenia Cognition Rating Scale (SCoRS-BR). Quality of life was assessed by the Brazilian version of the Quality of Life in Schizophrenia scale (QLS-BR). Results: The prevalence and titers of T. gondii IgM and IgG antibodies did not differ between patients and controls. The positive serology for T. gondii IgG antibodies was not associated with illness symptoms, cognitive performance, depressive symptoms or quality of life. Discussion: Our findings suggest that toxoplasmosis infection is not associated with severity of symptoms, quality of life, cognitive or depressive symptoms in schizophrenia patients.Universidade de São Paulo. Faculdade de Medicina. Instituto de Psiquiatria2017-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/acp/article/view/14487410.1590/0101-60830000000140Archives of Clinical Psychiatry; v. 44 n. 6 (2017); 145-148Archives of Clinical Psychiatry; Vol. 44 No. 6 (2017); 145-148Revista de Psiquiatria Clínica; Vol. 44 Núm. 6 (2017); 145-1481806-938X0101-6083reponame:Archives of Clinical Psychiatryinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/acp/article/view/144874/139101Copyright (c) 2018 Archives of Clinical Psychiatryinfo:eu-repo/semantics/openAccessCampos-Carli, Salvina Maria deVieira, Érica Leandro MarcianoRocha, Natalia PessoaOliveira, Keliane deGuimarães, Fernanda CarneiroBarbosa, Izabela GuimarãesBarros, João Luís Vieira Monteiro deOkusaga, OlaoluwaMartins-Filho, Olindo AssisSalgado, João ViníciusTeixeira, Antônio Lúcio2018-03-29T16:27:27Zoai:revistas.usp.br:article/144874Revistahttp://www.hcnet.usp.br/ipq/revista/index.htmlPUBhttps://old.scielo.br/oai/scielo-oai.php||archives@usp.br1806-938X0101-6083opendoar:2018-03-29T16:27:27Archives of Clinical Psychiatry - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Toxoplasma gondii infection and chronic schizophrenia: is there any association? |
title |
Toxoplasma gondii infection and chronic schizophrenia: is there any association? |
spellingShingle |
Toxoplasma gondii infection and chronic schizophrenia: is there any association? Campos-Carli, Salvina Maria de Toxoplasma gondii schizophrenia cognition depression quality of life |
title_short |
Toxoplasma gondii infection and chronic schizophrenia: is there any association? |
title_full |
Toxoplasma gondii infection and chronic schizophrenia: is there any association? |
title_fullStr |
Toxoplasma gondii infection and chronic schizophrenia: is there any association? |
title_full_unstemmed |
Toxoplasma gondii infection and chronic schizophrenia: is there any association? |
title_sort |
Toxoplasma gondii infection and chronic schizophrenia: is there any association? |
author |
Campos-Carli, Salvina Maria de |
author_facet |
Campos-Carli, Salvina Maria de Vieira, Érica Leandro Marciano Rocha, Natalia Pessoa Oliveira, Keliane de Guimarães, Fernanda Carneiro Barbosa, Izabela Guimarães Barros, João Luís Vieira Monteiro de Okusaga, Olaoluwa Martins-Filho, Olindo Assis Salgado, João Vinícius Teixeira, Antônio Lúcio |
author_role |
author |
author2 |
Vieira, Érica Leandro Marciano Rocha, Natalia Pessoa Oliveira, Keliane de Guimarães, Fernanda Carneiro Barbosa, Izabela Guimarães Barros, João Luís Vieira Monteiro de Okusaga, Olaoluwa Martins-Filho, Olindo Assis Salgado, João Vinícius Teixeira, Antônio Lúcio |
author2_role |
author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Campos-Carli, Salvina Maria de Vieira, Érica Leandro Marciano Rocha, Natalia Pessoa Oliveira, Keliane de Guimarães, Fernanda Carneiro Barbosa, Izabela Guimarães Barros, João Luís Vieira Monteiro de Okusaga, Olaoluwa Martins-Filho, Olindo Assis Salgado, João Vinícius Teixeira, Antônio Lúcio |
dc.subject.por.fl_str_mv |
Toxoplasma gondii schizophrenia cognition depression quality of life |
topic |
Toxoplasma gondii schizophrenia cognition depression quality of life |
description |
Background: Toxoplasma gondii (T. gondii) infection has been identified as a risk factor for schizophrenia. Objectives: Herein, we sought to evaluate the association between T. gondii infection and clinical symptoms and quality of life in patients with schizophrenia. Methods: We conducted a cross-sectional study with 48 patients with chronic schizophrenia and 40 controls. Peripheral blood was drawn, and IgM and IgG anti-T. gondii antibodies were evaluated by Enzyme-Linked Immunosorbent Assay (ELISA). Depressive, positive and negative symptoms were assessed, respectively, by the Calgary Depression Scale (CDS) and the Positive and Negative Syndrome Scale (PANSS). Cognitive performance was assessed in patients by the Brazilian version of the Schizophrenia Cognition Rating Scale (SCoRS-BR). Quality of life was assessed by the Brazilian version of the Quality of Life in Schizophrenia scale (QLS-BR). Results: The prevalence and titers of T. gondii IgM and IgG antibodies did not differ between patients and controls. The positive serology for T. gondii IgG antibodies was not associated with illness symptoms, cognitive performance, depressive symptoms or quality of life. Discussion: Our findings suggest that toxoplasmosis infection is not associated with severity of symptoms, quality of life, cognitive or depressive symptoms in schizophrenia patients. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-12-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/acp/article/view/144874 10.1590/0101-60830000000140 |
url |
https://www.revistas.usp.br/acp/article/view/144874 |
identifier_str_mv |
10.1590/0101-60830000000140 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/acp/article/view/144874/139101 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2018 Archives of Clinical Psychiatry info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2018 Archives of Clinical Psychiatry |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Medicina. Instituto de Psiquiatria |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Medicina. Instituto de Psiquiatria |
dc.source.none.fl_str_mv |
Archives of Clinical Psychiatry; v. 44 n. 6 (2017); 145-148 Archives of Clinical Psychiatry; Vol. 44 No. 6 (2017); 145-148 Revista de Psiquiatria Clínica; Vol. 44 Núm. 6 (2017); 145-148 1806-938X 0101-6083 reponame:Archives of Clinical Psychiatry instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Archives of Clinical Psychiatry |
collection |
Archives of Clinical Psychiatry |
repository.name.fl_str_mv |
Archives of Clinical Psychiatry - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||archives@usp.br |
_version_ |
1800237623846895616 |